Dollars and Sense - Strategies for Communicating with Cancer Patients About Financing Affordable and Effective Treatment

SELF STUDY / ENDURING - ESTIMATED TIME TO COMPLETE ACTIVITY: 60 Minutes

Navigating the process to procure treatment can be challenging for patients with cancer. In this webcast, expert faculty discuss communication strategies for cancer patients regarding access to financing affordable and effective treatment and the oral chemotherapy procurement process. The impact of rising prices on treatment delays and tactics to help patients with high copays obtain their medications will also be discussed. This webcast provides an opportunity to understand how financial oncology coordinators and specialty pharmacists collaborate to support financing the oncology patient’s treatment plan as well as identify communication strategies that can assist advanced practice providers in establishing an open and reciprocal dialogue with cancer patients about their financial support needs during all phases of oncology care.

Target Audience

This CME initiative was designed for oncologists, surgeons, radiation oncologists, NPs, PAs, pharmacists, nurses, and other healthcare professionals involved in the treatment of patients with cancer.

Learning Objectives

 

1. Describe how oncology financial coordinators and specialty pharmacists collaborate to support financing the oncology patient's treatment plan

2. Identify communication strategies that can assist Advanced Practice Providers in establishing an open and reciprocal dialogue with cancer patients about their financial support needs during all phases of oncology care

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
    Horizon CME designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 1.00 credit.
Course opens: 
09/02/2022
Course expires: 
09/02/2023
Cost:
$0.00
Rating: 
0

Faculty

Jason Wing PharmD

Born and raised in Indiana, Jason Wing attended pharmacy school at Purdue University. He completed his PGY1 acute care residency at UC San Diego Health and PGY2 oncology residency at OHSU Health. He is now a clinical oncology pharmacist that works both in the inpatient and ambulatory settings, focusing on the treatment of solid tumor patients. On top of his clinical responsibilities, he precepts students and residents on their oncology rotations and research projects, oversees chemotherapy infusion plan development for prostate, testicular, and head and neck cancer as a Via oncology disease state lead, serves as a member of the research council at OHSU Health and BCOP Oversight Committee for HOPA, and manages the newly implemented pharmacist managed IVIG protocol at OHSU Health.

DISCLOSURES:

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Horizon CME (HCME) ensures that continuing education activities are balanced, independent, objective, and scientifically rigorous.

All persons in a position to influence the content of an accredited continuing education activity provided by Horizon CME are required to disclose to HCME any relevant financial relationships with ineligible companies within the past 24 months. All reported relevant financial relationships have been mitigated by Horizon CME.

Jason Wing  Has no relevant disclosures

Available Credit

  • 1.00 AMA PRA Category 1 Credit
    Horizon CME designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 1.00 credit.

Price

Cost:
$0.00
Please login or register to take this course.

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Participate in the online activity.
  3. Complete the post-test and score a minimum of 70%
  4. Submit the evaluation form.

 

Required Hardware/software

 

Access to the internet is required.

Supported Browsers:

Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6.0+ for Mac OSX 10.7 and above

 

Supported Phones & Tablets:

 Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above

 

DISCLOSURE OF UNLABELED USE:

Horizon CME requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER:

This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.